N eutrophil priming refers to a process whereby exposure of these cells to various inflammatory mediators (e.g., LPS, TNF-␣, or GM-CSF) greatly enhances subsequent agonist-induced respiratory burst activity and degranulation responses (1) . While this event improves the ability of neutrophils to locate and kill invading microorganisms, priming is also implicated in neutrophil-mediated tissue injury both in vitro and in vivo (2, 3) . Hence, the recruitment of large numbers of such hyperresponsive cells at an inflammatory focus may predispose to tissue injury and contribute to a variety of neutrophil-mediated diseases, including acute respiratory distress syndrome, rheumatoid arthritis, and ischemia-reperfusion injury (4) . Priming also has a direct effect on neutrophil shape, deformability, integrin/selectin expression, and longevity (1, 5) , and, as a consequence, has a profound effect on the rheological, adhesive, and survival properties of these cells in vivo (6) . More recently we have shown that priming is a reversible process and that neutrophils can cycle among unprimed, primed, deprimed, and reprimed states (7) , underscoring the dynamic nature of this process. Despite the important role of neutrophil priming in a range of serious and often treatment-resistant conditions, the signaling mechanisms underlying this process remain poorly characterized.
Previous reports have indicated a pivotal role for phosphatidylinositol 3-kinase (PI3-kinase) 4 in neutrophil activation (8, 9) . In mammalian cells the type Ia (PI3-kinase-␣␤␦) and type Ib (PI3-kinase-␥) PI3-kinases catalyze the conversion of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) to phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) (10) , and this molecule has been shown to be involved in the recruitment and activation of a variety of regulatory proteins via an interaction with their PH domains (11) . In the neutrophil, agonist activation or the addition of GTP to permeabilized cells results in a rapid and robust increase in PtdIns(3,4,5)P 3 accumulation (10, 12) , and inhibitors of PI3-kinase abolish agonist-stimulated superoxide anion (O 2 Ϫ ) generation (8) . Moreover, we have recently demonstrated that a metabolic product of PtdIns(3,4,5)P 3 , PtdIns(3)P, is generated in phagocytic membranes (13) and directly regulates the neutrophil oxidase complex by binding to the PX domain of p40 phox (14) .
While priming is an obligate step required for full activation of the NADPH oxidase, the impact of this process on agonist-stimulated PtdIns(3,4,5)P 3 accumulation and the precise PI3-kinase isoforms responsible for this response have not been defined. Our preliminary studies using [ 32 P]P i -labeled neutrophils (1) and those of Kodama et al. (15) suggest that priming may enhance fMLPstimulated [ 32 P]PtdIns(3,4,5)P 3 accumulation, but the kinetics, magnitude, and mechanism of this effect remain to be determined. Identifying the PI3-kinase(s) involved in this response is complicated by the presence of an additional, myeloid-restricted, G␤␥-regulated PI3-kinase (p101/PI3-kinase-␥) in neutrophils and the lack of high-affinity p101 or PI3-kinase-␥ Abs or PI3-kinase isoform selective inhibitors. The potential importance of PI3-kinase-␥ in neutrophil activation is supported by data in p110␥ knockout mice where defects in respiratory burst and migratory responses have been observed (9, 16) . However, murine neutrophils have a very attenuated respiratory burst response compared with human neutrophils, and priming has not been clearly demonstrated in this species.
In the current study we have measured PtdIns(3,4,5)P 3 accumulation using a recently developed mass assay (17). We show that neutrophil priming with TNF-␣, GM-CSF, cytochalasin B, or platelet-activating factor (PAF) before fMLP stimulation leads to a substantially prolonged PtdIns(3,4,5)P 3 signal. Manipulation of the O 2 Ϫ response using a number of PI3-kinase and tyrosine kinase inhibitors, and also allowing neutrophils to deprime after PAF exposure, resulted in parallel changes in both PtdIns(3,4,5)P 3 accumulation and O 2 Ϫ release. Moreover, significant PI3-kinase activity could be detected in p110␥, but not p85 or phosphotyrosine immunoprecipitates, after TNF-␣ priming or fMLP stimulation. Finally, priming did not affect the extent of basal or fMLP-stimulated p21 ras activity, an upstream regulator of PI3-kinase. Together, these results suggest that enhanced PI3-kinase-␥ activity underlies the augmented accumulation of PtdIns(3,4,5)P 3 and O 2 Ϫ response seen in primed neutrophils, and that a PI3-kinase regulatory protein other than p21 ras controls this activity.
Materials and Methods

Materials
Percoll, dextran, [␥-32 P]ATP, and the ECL detection kit were obtained from Amersham Pharmacia Biotech (Piscataway, NJ). Cytochrome c, superoxide dismutase, fMLP, LPS, and PBS (with or without CaCl 2 and MgCl 2 ) were purchased from Sigma Chemical (Poole, Dorset, U.K.). [Inositol-1-[ 3 H] (N)]-1,3,4,5-tetrakisphosphate was supplied by NEN Life Science (Boston, MA) and inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P 4 ) was supplied by Cell Signals (Lexington, KY). Human rTNF-␣ and GM-CSF were supplied by R&D Systems (Abingdon, U.K.). The p110␥ Ab (LS1/127) was raised in mice against a Sf9 cell-expressed His-tagged fulllength protein (porcine sequence); p85 and 4G10 Abs were from Upstate Biotechnology (Lake Placid, NY). PAF-18 (1-O-stearyl-2-acetyl-sn-glycero-3-phosphocholine), LY294002, pan-Ras Ab, staurosporine, genistein, cytochalasin B, and radicicol were purchased from Calbiochem (La Jolla, CA). All other reagents were obtained from commercial sources and were of the highest purity available.
Preparation of human neutrophils
Human neutrophils were prepared from peripheral blood of healthy volunteers using dextran sedimentation and discontinuous plasma-Percoll gradients as previously described (18) . This method routinely yielded cells that were unprimed and Ͼ95% pure with Ͻ0.1% mononuclear cell contamination.
O 2 Ϫ release assay
Purified neutrophils (10 6 /90 l PBS containing CaCl 2 and MgCl 2 ) were equilibrated at 37°C in a gently shaking water bath for 5 min. Priming agents were added to give final concentrations of 200 U/ml TNF-␣, 100 ng/ml GM-CSF, 5 M cytochalasin B, or 1 M PAF. Cells were primed for the periods stated and then stimulated with fMLP (100 nM) or vehicle in the presence of prewarmed cytochrome c (final concentration 1.2 mg/ml in PBS). O 2 Ϫ release was calculated from the superoxide dismutase-inhibitable reduction of cytochrome c (1).
Ins (1, 3, 4, 5) 6 ) were primed with TNF-␣ (200 U/ml) or GM-CSF (100 ng/ml) for 30 min. Vehicle or fMLP (100 nM) was added for the indicated times and the reactions were stopped by the addition of methanol/chloroform (2:1, v/v). Lipid extractions were performed as previously described (1) . After drying, the samples were processed as detailed (17) and stored at Ϫ20°C until analyzed. Immediately before the assay, samples were resuspended in dilute acetic acid to a final pH of 5. The Ins(1,3,4,5)P 4 radioreceptor assay was performed as described (20) 
PI3-kinase activity assays
Neutrophils (20 ϫ 10 6 cells) were primed and stimulated as described. After stimulation, 1 ml of ice-cold lysis buffer (10 mM Tris-HCl (pH 7.8), 1.5 mM EDTA, 10 mM KCl, 0.1% Nonidet P-40, 1 mM Na 3 VO 4 , 0.1 mM di-isopropylfluorophosphate, 0.1 mM N-␣-tosyl-L-lysine chloromethyl ketone, 0.1 mM DTT, 10 g/ml aprotinin, 10 g/ml pepstatin, and 10 g/ml leupeptin) was added and the samples were left on ice for 20 min with intermittent vortex mixing. Samples were sonicated (2 ϫ 10 s at maximum setting) and then centrifuged. The supernatants were collected and incubated with p85, 4G10, and p110␥ Ab overnight and protein A Sepharose beads were added for a further 2 h. The beads were collected and washed once with lysis buffer, once with 100 mM Tris/500 mM LiCl (pH 7.6), and twice with 200 mM HEPES, 40 mM MgCl 2 , 600 mM NaCl (pH 7.4). The washed beads were then incubated for 10 min at 30°C in buffer (200 mM HEPES, 40 mM MgCl 2 , 600 mM NaCl ((pH 7.4)) together with phosphatidylinositol/phosphatidylserine (3:1, 0.2 mg/ml) vesicles, 10 Ci [ 32 P]ATP, and 50 M unlabeled ATP. Lipid extractions were performed as previously detailed (22) and the lower organic phase was dried in an Eppendorf concentrator, redissolved in chloroform, and spotted onto silica gel 60 TLC plates. The plates were run in a solvent system containing chloroform/methanol/ammonia/water (20:14:3:5, v/v/v/v). The 32 P-labeled phosphoinositide 3-phosphate band was detected by autoradiography and [ 32 P] incorporation measured by liquid scintillation counting. In experiments characterizing the mouse p110␥ mAb (LS1/127), PI3-kinase activity was assayed as described by Stephens et al. (12) with the lipid products deacylated before resolution by TLC.
Transfection of COS7 cells with EE-tagged p110␥
Rapidly growing COS7 cells were cultured to 40 -60% confluence in DMEM containing 10% FBS, washed twice in serum-free DMEM buffered with 10 mM HEPES (pH 7.3), and incubated with 1 g Glu-Glu (EEtagged) p110␥ DNA/0.5 ml serum-free DMEM together with 125 g DEAE-dextran (23) . The cells were incubated for 90 min at 37°C with the DNA solution followed by 5 h with DMEM containing 100 M chloroquine. Cells were used 24 -48 h after transfection. Cell lysis, protein immunoprecipitation (using LS1/127 Ab-coupled protein G-Sepharose beads), SDS-PAGE, and Western blotting were performed as previously detailed (24) .
Measurement of activated p21 ras using Raf1 Ras binding domain (RBD)
Neutrophils (1.5 ϫ 10 7 /sample in 80 l PBS with divalent cations) were primed (200 U/ml TNF-␣, 100 ng/ml GM-CSF, or appropriate diluent) for 30 min at 37°C and stimulated with 100 nM fMLP or buffer for 10 -300 s. Reactions were stopped with ice-cold lysis buffer (100 mM NaCl, 50 mM HEPES (pH 7.5), 1% Triton X-100, 1 mM EDTA (pH 8), 1 mM EGTA (pH 8), 5 mM NaF, 12 mM MgCl 2 , 1 mM Na 3 VO 4 , and 10 g/ml aprotinin, pepstatin, leupeptin, and antipain). Nuclei were removed by centrifugation and precoupled GST-RBD beads added to the lysates before incubation at 4°C for 30 min. Beads were washed three times with cold PBS containing 5 mM MgCl 2 and 0.1% Triton X-100, and subsequently boiled in Laemmli sample buffer. Protein samples were separated by SDS-PAGE and Western blotted with a pan-Ras Ab. Blots were developed using ECL Plus detection reagents.
Statistics
Data are presented as the mean Ϯ SEM of n separate experiments. Data were analyzed using the Student t test or ANOVA followed by the StudentKewan-Keuls post-test. Results were considered to be significant with p Ͻ 0.05. 
Results
PtdIns(3,4,5)P 3 mass assay
PtdIns(3,4,5)P 3 has been proposed to be an important second messenger in O 2 Ϫ generation in phagocytic cells (8, 26) . Traditional methods of measuring PtdIns(3,4,5)P 3 accumulation involve metabolic labeling of cells with [ 32 P]PO 4 followed by HPLC analysis of individual sample extracts. Moreover, the incubation times and conditions required to achieve true isotopic equilibrium labeling of the agonist-sensitive PtdIns(4,5)P 2 pool in neutrophils invariably result in significant basal priming. These factors have precluded a detailed analysis of the effects of cytokine-mediated priming on agonist-stimulated PtdIns(3,4,5)P 3 accumulation in neutrophils.
To address these problems we have used a recently described PtdIns(3,4,5)P 3 mass assay (17) based on the ability of boiling KOH to convert, in a quantitative manner, cell-extracted PtdIns(3,4,5)P 3 to its water-soluble counterpart, Ins(1,3,4,5)P 4 . This product can be measured by competitive radioreceptor assay using a bacterially expressed GST-tagged GAP-Ins(1,3,4,5)P 4 Ϫ generation in human neutrophils. Cells were primed with 200 U/ml TNF-␣ (b) or 100 ng/ml GM-CSF (d) for 30 min and then stimulated with 100 nM fMLP for 10 min in the presence of cytochrome c. O 2 Ϫ release was measured by the superoxide dismutase-inhibitable reduction of cytochrome c. Data points represent mean Ϯ SEM of three separate experiments, each performed in triplicate. c and e, The corresponding time courses of PtdIns(3,4,5)P 3 accumulation in primed and stimulated neutrophils. For PtdIns(3,4,5)P 3 measurements, cells were primed with 200 U/ml TNF-␣ (c) or 100 ng/ml GM-CSF (e) for 30 min and then stimulated with 100 nM fMLP for various times. Ⅺ, Control; ᭜, TNF-␣ or GM-CSF; E, fMLP; OE, TNF-␣ or GM-CSF followed by fMLP. Reactions were stopped by the addition of MeOH/CHCl 3 (2:1 v/v), lipids were extracted, and the Ins(1,3,4,5)P 4 mass assay was performed as described. Results are mean Ϯ SEM of duplicate samples from three independent experiments (d) or the means Ϯ SD of duplicate samples from one experiment representative of three independent experiments (e).
binding protein (GAP IP4BP ). A typical calibration curve for the displacement of [ 3 H]Ins(1,3,4,5)P 4 from the GAP IP4BP by unlabeled Ins(1,3,4,5)P 4 is shown in Fig. 1a (K d 3.9 Ϯ 0.38 nM; n ϭ 5). The specificity of the assay for Ins(1,3,4,5)P 4 was confirmed in this system using authentic Ins(1,4, 5)P 3 . As shown in Fig. 1a , no significant displacement of [ 3 H]Ins(1,3,4,5)P 4 binding was observed with up to 120 pmol of Ins(1,4, 5)P 3 . The recovery of Ins(1,3,4,5)P 4 during the extraction process (determined using spiked [ 3 H]Ins(1,3,4,5)P 4 ) was 93% (data not shown). Assay values for each sample were corrected for these losses and the efficiency of PtdIns(3,4,5)P 3 to Ins(1,3,4,5)P 4 conversion (62%) and expressed as pmol PtdIns(3,4,5)P 3 /8 ϫ 10 6 neutrophils.
Effect of neutrophil priming on fMLP-stimulated PtdIns(3,4,5)P 3 accumulation
As previously demonstrated, quiescent neutrophils or those treated with TNF-␣ (200 U/ml) or fMLP (100 nM) alone released minimal O 2 Ϫ , whereas cells primed with TNF-␣ and subsequently stimulated with fMLP showed greatly enhanced O 2 Ϫ release (Fig. 1b) . A detailed time course of fMLP-stimulated PtdIns(3,4,5)P 3 mass accumulation was undertaken in TNF-␣-primed or unprimed neutrophils. Cells exposed to TNF-␣ or vehicle alone showed minimal PtdIns(3,4,5)P 3 accumulation compared with values obtained in freshly isolated cells (Fig. 1c) . fMLP stimulation of unprimed cells resulted in a rapid but transient increase in PtdIns(3,4,5)P 3 accumulation with peak values between 5 and 15 s (Fig. 1c) . In contrast, cells primed with TNF-␣ and then stimulated with fMLP showed a greater increase in PtdIns(3,4,5)P 3 accumulation at early times and a sustained elevation in PtdIns(3,4,5)P 3 levels lasting for at least 60 s (Fig. 1c) . Similar data were obtained with the alternative priming agent GM-CSF (Fig. 1, d and e) , suggesting that the ability of TNF-␣ to enhance fMLP-stimulated PtdIns(3,4,5)P 3 accumulation is a "class effect" and is shared by other priming agents.
To test this hypothesis further, the effects of an alternative nonreceptor-acting priming agent, cytochalasin B, were also examined. Table I shows that cytochalasin B significantly increased both O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation in a similar manner to TNF-␣ and GM-CSF, suggesting that a broad array of priming agents activate these responses through the same signaling pathways.
PtdIns(3,4,5)P 3 and O 2 Ϫ responses in neutrophils after transient priming with PAF
We have demonstrated previously that neutrophils primed with PAF spontaneously "deprime" over a period of 120 min even if left continuously exposed to PAF (7). Fig. 2a confirms that the ability of PAF to enhance fMLP-stimulated O 2 Ϫ generation in neutrophils is transient, with the priming effect completely lost by 120 min. Previous studies have shown that cells exposed to PAF in this way remain viable throughout this incubation period, revert to a fully depolarized state with normal CD11b expression, and indeed are capable of being "reprimed" by a second priming agent such as TNF-␣ (7).
To compare PtdIns(3,4,5)P 3 responses in primed and deprimed cells, neutrophils were incubated with PAF for 10 or 120 min before stimulation with fMLP for 45 s. This latter time point was chosen for this and subsequent experiments because it gave the greatest discrimination between PtdIns(3,4,5)P 3 responses in acutely primed and unprimed cells (Fig. 1, c and e) . In agreement with the previous data with TNF-␣ and GM-CSF, cells treated with PAF for 10 min and then stimulated with fMLP showed a large increase in O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation compared with unprimed, fMLP-stimulated cells (Fig. 2) . In contrast, cells treated with PAF for 120 min displayed O 2 Ϫ and PtdIns(3,4,5)P 3 responses identical to unprimed cells (Fig. 2) . Time-matched controls were included where cells were incubated for 2 h before the addition of PAF, showing that the O 2 Ϫ and 
Effects of PI3-kinase and protein kinase inhibitors on O 2
Ϫ and PtdIns (3, 4, 5 
)P 3 generation
Consistent with previous results, LY294002, a well-characterized and highly selective inhibitor of PI3-kinase activity, inhibited fMLP-stimulated O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation in both primed and unprimed cells (Fig. 3, a and e) . Identical data were obtained with the alternative PI3-kinase inhibitor wortmannin (data not shown). These results confirm the involvement of a type I or III PI3-kinase in O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation in human neutrophils.
To explore the involvement of a tyrosine kinase-regulated PI3-kinase in the priming-associated increase in O 2 Ϫ and PtdIns(3,4,5)P 3 responses in neutrophils, the effects of a group of protein kinase inhibitors with variable tyrosine kinase activity were examined. Genistein is a protein tyrosine kinase inhibitor that, at high concentrations, has a broader spectrum of activity reflecting its ability to act as a competitive inhibitor of ATP. Pretreatment of neutrophils with genistein resulted in a concentrationdependent inhibition of fMLP-stimulated O 2 Ϫ generation (Fig. 3b) and a matched inhibition of PtdIns(3,4,5)P 3 accumulation (Fig. 3f) . Genistein was effective only at concentrations Ͼ10 M, suggesting that its effect may be due to inhibition of alternative (nontyrosine) kinases. Staurosporine is a broad-spectrum serine/threonine protein kinase and protein kinase C (PKC) inhibitor that has the paradoxical ability to augment rather than inhibit agonist-stimulated respiratory burst activity in neutrophils (27) . Fig. 3, c and g , demonstrates the ability of staurosporine to increase both fMLP-stimulated O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation in primed and unprimed cells. This again demonstrates the close association between these two events and the potential involvement of a PKCdependent pathway in inhibiting PtdIns(3,4,5)P 3 accumulation.
The most discriminating inhibitor used in this set of experiments was radicicol, which is an antifungal antibiotic with selective anti-tyrosine kinase properties that has been reported to block Lyn-dependent activation of p85 PI3-kinase and yet has no direct inhibitory effect on the G␤␥-regulated p101/p110␥ (28). Importantly, radicicol was found to have no effect on fMLP-stimulated O 2 Ϫ generation or PtdIns(3,4,5)P 3 accumulation in primed or unprimed cells (Fig. 3, d and h ), despite causing a concentration-dependent and complete inhibition of platelet-derived growth factor (PDGF)-stimulated [ 3 H]thymidine incorporation in BTSM (Fig. 3i) ; we have previously shown this latter response to reflect activation of a tyrosine kinase-dependent p85 PI3-kinase pathway Ϫ and PtdIns(3,4,5)P 3 accumulation in primed/stimulated neutrophils. O 2 Ϫ generation was measured as described after treatment for 20 min at 37°C with 50 M LY294002 (a) and varying concentrations of genistein (b) or staurosporine (c) before addition of buffer (E) or TNF-␣ (F) (200 U/ml for 30 min) and then stimulated with fMLP (100 nM for 10 min). Cells were treated with radicicol for 2.5 h before TNF-␣ priming and fMLP stimulation (d). Cells were treated with the various inhibitors described above (e, 50 M LY294002; f, 400 M genistein; g, 1 M staurosporine; h, 400 ng/ml radicicol) and primed with TNF-␣ (200 U/ml) or buffer for 30 min before stimulation for 45 s with 100 nM fMLP. The amount of PtdIns(3,4,5)P 3 accumulated was measured as described. Results are the means Ϯ SEM of three independent experiments performed in duplicate. i, [ 3 H]Thymidine incorporation was measured in quiescent BTSM cells stimulated with 20 ng/ml PDGF (f) for 24 h in the presence of increasing concentrations of radicicol as described in Materials and Methods. (21) . Radicicol was also found to inhibit thrombin-stimulated DNA synthesis in BTSM cells (data not shown).
These results in primed, deprimed, and kinase inhibitor-manipulated cells underscore the close correlation between PtdIns(3,4,5)P 3 accumulation and O 2 Ϫ generation in neutrophils. The radicicol data in particular also suggest the involvement of the G␤␥-regulated p101/p110␥ PI3-kinase in the augmented PtdIns(3,4,5)P 3 and O 2 Ϫ responses seen under TNF-␣-primed conditions.
Determination of which PI3-kinase isoforms are responsible for enhanced PtdIns(3,4,5)P 3 accumulation under primed/stimulated conditions
To determine more precisely which PI3-kinase isoforms are responsible for the enhanced PtdIns(3,4,5)P 3 production observed in primed neutrophils, selective immunoprecipitation-based PI3-kinase assays were performed. Positive control data for the experiments involving 4G10 and p85 immunoprecipitations were obtained using primary BTSM cells stimulated with PDGF (20 ng/ml for 10 min). Fig. 4a demonstrates the substantial increase in PI3-kinase activity associated with 4G10 anti-phosphotyrosine immunoprecipitates in BTSM cells after stimulation with PDGF. In contrast, 4G10 (Fig. 4b) and p85 (Fig. 4d) immunoprecipitates prepared from primed and fMLP-stimulated (45 s) neutrophils showed no increase in PI3-kinase activity over control levels. Of note, wortmannin was able to fully inhibit p85-associated PI3-kinase activity (Fig. 4d) , confirming the specificity of this assay. These results concur with the data obtained using radicicol and imply that the increases observed in PtdIns(3,4,5)P 3 accumulation under primed/stimulated conditions do not reflect activation of a tyrosine kinase-linked p85/p110␣, ␤, or ␦ PI3-kinase.
To detect changes in the G␤␥-regulated isoform of PI3-kinase (p101/p110␥) activity under primed/activated conditions, a mouse mAb (LS1/127, IgM isotype-chain) was raised against Histagged p110␥ expressed in Sf9 insect cells (29) . The LS1/127 Ab was able to immunoprecipitate EE-tagged p110␥ from transfected COS7 cells with a similar efficiency to EE beads (Fig. 5a ) and identify specific cytoplasmic staining in Myc-p110␥ transfected COS7 cells (data not shown). LS1/127 was also able to immunoprecipitate p110␥ activity from porcine neutrophils (Fig. 5b) (but no other porcine tissues; data not shown) and from EE-p110␥ transfected COS7 cells (Fig. 5b) .
Use of this Ab demonstrated significant increases in PI3-kinase activity in p110␥ immunoprecipitates prepared from cells treated with TNF-␣ (200 U/ml for 30 min) or fMLP (100 nM for 45 s) alone and under primed/stimulated conditions compared with control levels (Fig. 5c) . Of note, Western blot analysis confirmed that an identical amount of p110␥ was immunoprecipitated from neutrophil lysates irrespective of the treatment conditions (data not shown). This result further supports the suggestion that priminginduced increases in fMLP-stimulated PtdIns(3,4,5)P 3 accumulation are mediated via enhanced activation of PI3-kinase-␥.
Effect of priming on fMLP-stimulated p21
ras activation
In view of these data and the previous demonstration that priming up-regulates mitogen-activated protein kinase activity (15), we investigated the effect of priming on p21 ras activation, an upstream regulator of both PI3-kinase and MEK1/2 responses. Human neutrophils primed with GM-CSF or TNF-␣ were stimulated with fMLP, and p21 ras activation was determined. While no GTPbound p21 ras was detected in either control cells or cells treated with TNF-␣ alone (Fig. 6, upper panel) , GM-CSF induced a slight increase in detectable GTP-Ras (Fig. 6, lower panel) . Stimulation with fMLP alone induced dramatic activation of p21 ras , maximal at 30 -60 s and diminishing to near baseline by 5 min (Fig. 6) . Priming with TNF-␣ did not augment this response. The minor increase in the fMLP-stimulated p21 ras signal seen in GM-CSFpretreated cells was purely additive when quantified by densitometry (data not shown). Thus, increased availability of GTP-bound p21 ras does not appear to underlie the enhancement of PtdIns(3,4,5)P 3 generation seen in primed/stimulated neutrophils.
Discussion
The PI3-kinase family plays a critical role in a variety of cellular functions, including survival, mitogenesis, vesicular trafficking, chemotaxis, and oxidative burst activity (11) . It would seem likely that many of the more universal cellular processes are controlled by the ubiquitous PI3-kinase isoforms, such as PI3-kinase-␣ and -␤, while specialized leukocyte functions are the province of the predominantly leukocyte-restricted PI3-kinase-␦ and -␥ isoforms. While defects in chemotaxis and oxygen radical formation seen in neutrophils derived from animals lacking PI3-kinase-␥ support this premise, these results cannot be extrapolated to human neutrophils, which undergo a far more intense and primeable O 2 Ϫ response compared with their murine counterparts. While Naccache et al. (30) have also demonstrated PI3-kinase activity in p110␥ but not p85 immunoprecipitates in fMLP-stimulated neutrophils, the impact of priming, which is an essential regulator of O 2 Ϫ generation, was not studied.
The main aims of this research were to extend the observation that PtdIns(3,4,5)P 3 accumulation correlates with, and may signal for, O 2 Ϫ generation, and to determine which PI3-kinase isoforms are responsible for the increases in fMLP-stimulated PtdIns(3,4,5)P 3 mass observed in primed cells. Because there is a lack of reagents, both Abs and inhibitors specific for the p110/p101 PI3-kinase-␥ isoform, several different experimental strategies were used to address this issue.
A radioligand displacement assay was used to measure total PtdIns(3,4,5)P 3 mass accumulation in primed and unprimed neutrophils after fMLP stimulation. This assay relies on the quantitative conversion of PtdIns(3,4,5)P 3 to Ins(1,3,4,5)P 4 under strong alkaline hydrolysis conditions and assay of the Ins(1,3,4,5)P 4 generated using a specific radioreceptor assay incorporating the GAP IP4BP . As previously reported (30, 31) , fMLP alone led to a rapid but transient increase in PtdIns(3,4,5)P 3 accumulation maximal at 5-15 s. However, after priming with either TNF-␣ or GM-CSF, fMLP resulted in a more robust and prolonged increase in PtdIns(3,4,5)P 3 accumulation, with PtdIns(3,4,5)P 3 levels remaining elevated for up to 2 min. Our earlier studies in metabolically labeled cells failed to detect any defect in the metabolism of FIGURE 6. Effect of priming on fMLP-stimulated p21 ras activation. Neutrophils (1.5 ϫ 10 7 /sample) were primed with 200 U/ml TNF-␣ or 100 ng/ml GM-CSF (30 min at 37°C) and stimulated with 100 nM fMLP (10 -300 s at 37°C) as indicated. Cell lysates were incubated with GST-RBD to bind GTP-p21 ras as described in Materials and Methods and samples were subjected to SDS-PAGE and Western blotting with a pan-Ras mAb. For each priming agent a single representative experiment of n ϭ 3 is shown.
FIGURE 5.
Involvement of PI3-kinase p110␥ in neutrophil activation. a, COS7 cells were either transfected with EE-tagged p110␥ (ϩ) or left untransfected (Ϫ). Lysates were immunoprecipitated with the indicated Abs, subjected to SDS-PAGE, and detected using LS1/38 anti-p110␥ Ab, in Western blots. b, Immunoprecipitates from U937 (15 mg), neutrophil cytosol (15 mg), and EE-p110␥ transfected COS cells were subjected to PI3-kinase assays followed by deacylation of the lipid products and TLC analysis as described. c, Human neutrophil cell lysates were made, immunoprecipitations with LS1/127 were performed, and PI3-kinase assays were conducted. Cells were primed with 200 U/ml TNF-␣ for 30 min and stimulated with 100 nM fMLP for 45 s. Results are shown as a percentage of the control response and are the means Ϯ SEM of three independent experiments performed in duplicate. The upper panel shows a representative autoradiogram of the appropriate region of the TLC plates.
PtdIns(3,4,5)P 3 to PtdIns(3,4)P 2 in these cells (1) , suggesting that the augmented accumulation of PtdIns(3,4,5)P 3 reflects enhanced production rather than inhibition of metabolism. Moreover, the reported ability of the NADPH oxidase to activate the PtdIns(3,4,5)P 3 -5 phosphatase Src homology 2 domain-containing inositol phosphatase-1 via a Lyn-dependent mechanism would predict that the metabolism of PtdIns(3,4,5)P 3 would be enhanced rather than inhibited after fMLP stimulation (32) . These data provide the first evidence of a difference in PtdIns(3,4,5)P 3 mass accumulation between fMLP-stimulated and primed/stimulated neutrophils. We also found that, while TNF-␣ treatment alone had no effect on PtdIns(3,4,5)P 3 levels at 30 min, GM-CSF incubation over the same period resulted in a small but consistent increase in PtdIns(3,4,5)P 3 accumulation. This agrees with previous work using metabolically labeled cells and estimates of [ (30, 33) . Of note, the priming status of the cells used in these experiments was confirmed by performing O 2 Ϫ release assays alongside each PtdIns(3,4,5)P 3 mass and immunoprecipitation assay to ensure that no biochemical analysis was undertaken in cells that had been inadvertently primed during cell isolation. Hence, any cells showing evidence of basal priming (i.e., having a ratio between TNF-␣/fMLP and fMLP O 2 Ϫ generation of Ͻ4) were discarded. Other priming agents were also examined to determine whether all such agents caused similar increases in O 2 Ϫ and PtdIns(3,4,5)P 3 responses. Cytochalasin B was found to prime both O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation after 45 s of fMLP stimulation in a similar manner to that observed with TNF-␣. Cytochalasin B is a non-G protein receptor-mediated agonist that has been widely used to induce neutrophil priming; however, its exact mode of action is not known and may involve other pathways besides PI3-kinase. The effects of LPS were also examined and, while both O 2 Ϫ and PtdIns(3,4,5)P 3 responses were increased, in the absence of serum the effects were much less dramatic than those observed with the other priming agents used (data not shown).
The ability of neutrophils to spontaneously "deprime" after exposure to PAF for 120 min was also investigated. Previous work from our group has shown that full priming (equivalent to that seen with TNF-␣ or GM-CSF at 30 min) is observed 10 min after PAF addition; thereafter the cells regain their nonpolarized rounded morphology, and CD11b/18 expression and function and O 2 Ϫ responses return to normal (7). Our results confirm normalization of the O 2 Ϫ responses after a 120-min incubation with PAF and show a parallel decline in fMLP-stimulated PtdIns(3,4,5)P 3 accumulation at a time point (45 s) that coincides with maximal respiratory burst activity (1) .
Using a variety of PI3-kinase and other kinase inhibitors we have been able to show a remarkably similar response profile with respect to O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation. Both PtdIns(3,4,5)P 3 and O 2 Ϫ generation was severely inhibited by LY294002, confirming the involvement of a PI3-kinase in both of these responses. The tyrosine kinase inhibitor genistein was also found to inhibit both PtdIns(3,4,5)P 3 and O 2 Ϫ generation, albeit at relatively high concentrations. Staurosporine, a serine/threonine protein kinase and PKC inhibitor, was found to increase both fMLP-stimulated O 2 Ϫ generation and PtdIns(3,4,5)P 3 accumulation to levels equal to or higher than those observed with TNF-␣ priming. This rather surprising "priming" effect of staurosporine has also been observed by other workers (27) ; however, the mechanism remains to be defined. More importantly, the lack of inhibition observed with radicicol, a selective tyrosine kinase inhibitor that lacks activity against the G␤␥-regulated PI3-kinase (28) but abolished p85-regulated PI3-kinase activity in BTSM cells (Fig. 3i and Ref. 21) , suggested that the enhanced O 2 Ϫ and PtdIns(3,4,5)P 3 signal observed under priming conditions occurs via the p101/ p110␥ PI3-kinase rather than through a tyrosine kinase-regulated process. However, it is possible that a component of the fMLPstimulated PtdIns(3,4,5)P 3 response observed in unprimed cells originates from an alternative PI3-kinase; the data of Ptasznik et al. (28) , who have shown that radicicol can inhibit fMLP-stimulated PtdIns(3,4,5)P 3 production in unprimed cells, support this conclusion.
Using more traditional lipid kinase assays to measure PI3-kinase activity, we found that fMLP was unable to stimulate PI3-kinase activity in either p85 or 4G10 immunoprecipitates, irrespective of the priming status of these cells. These data were obtained in the face of clearly positive signals in PDGF-stimulated BTSM cells and again point to the lack of involvement of a tyrosine kinaseregulated form of PI3-kinase in the PtdIns(3,4,5)P 3 responses observed at 45 s post-agonist addition. While such data agrees with that obtained by Naccache et al. (30) , Stephens et al. (10) , and Vlahos et al. (34) , other groups have reported enhanced PI3-kinase activity in p85 immunoprecipitates from neutrophils (35, 36) . However, in the latter study (36) , lysates were prepared from adherent cells treated with TNF-␣ and it is possible that this, as well as the use of different primary Abs, may underlie such differences.
In agreement with Naccache et al. (30), we were able to show significant involvement of the p110␥ subunit in neutrophil PI3-kinase activity after fMLP treatment. However, the increased PI3-kinase activity observed in p110␥ immunoprecipitates prepared from cells treated with TNF-␣ alone was surprising, because there was no accompanying increase in PtdIns(3,4,5)P 3 accumulation. While it is possible that TNF-␣ enhances PtdIns(3,4,5)P 3 degradation (and this would concur with the small increases in [ 32 P]PtdIns3P accumulation in TNF-␣-treated neutrophils previously reported (1)), effects of priming agents on Src homology 2 domain-containing inositol phosphatase-1 and the PtdIns(3,4)P 2 -4 phosphatases are not described. It is also possible that the enzyme has limited access to PtdIns(4,5)P 2 or, more likely, that the absence of activated G␤␥ subunits precludes PI3-kinase-␥ activation in the intact cell. Similar explanations could pertain to the lack of difference in PI3-kinase-␥ activity observed between unprimed and primed cells treated with fMLP. New insights into how 3-phosphorylated lipids might control the assembly and hence activity of the neutrophil NADPH oxidase complex have come from recent work demonstrating that components of the enzyme complex, namely p47 phox and p40 phox , bind PtdIns(3,4)P 2 and PtdIns3P (both breakdown products of PtdIns(3,4,5)P 3 ), respectively, via PX domains (14) . Therefore, it seems likely that PtdIns(3,4,5)P 3 degrading enzymes may be intimately involved in the control of the oxidase response.
The p85 and G␤␥-regulated forms of PI3-kinase have both been shown to bind p21 ras , and indeed ras is thought to be an important upstream regulator of PI3-kinase. Additional data suggest that p21 ras can also be a target of PI3-kinase (37) . Ras also regulates the activity of the MEK1/2 pathway, which is also known to be up-regulated after priming (15) . Despite this, we demonstrated that TNF-␣ had no effect on the amount of active, GTP-bound p21 ras present in neutrophils and failed to influence the strength of the fMLP-stimulated signal. Likewise, fMLP alone caused robust activation of p21 ras , with GM-CSF having an intermediate effect. While we have not excluded the possibility that priming agents alter the activity of p21 ras within the detergent-insoluble neutrophil fraction, our data concur with those reported by Coffer et al. (35) and suggest a dissociation between p21 ras activity and both O 2 Ϫ release and PtdIns(3,4,5)P 3 accumulation. Thus, these data indicate that priming agents enhance PI3-kinase-␥ activity by factors other than p21
ras . Because previous studies have shown that priming-mediated effects on receptor expression are temporally dissociated from the up-regulation of secretory responses and that fMLP-stimulated Ins(1,4,5)P 3 accumulation is unaffected by priming (1), other mechanisms, including the regulation of G i subunit expression (38) or factors affecting PI3-kinase localization or substrate access, need to be considered.
In conclusion, priming represents a major checkpoint controlling the functional responsiveness of neutrophils to secretagogue agonists and, as such, their capacity to induce tissue damage in vivo. We have demonstrated the close relationship between fMLPstimulated PtdIns(3,4,5)P 3 accumulation and O 2 Ϫ generation under conditions of (TNF-␣, GM-CSF, cytochalasin B, and PAFinduced) priming, depriming, and kinase inhibition and present evidence to suggest that the G␤␥-regulated PI3-kinase (P101/ p110␥) is the dominant PI3-kinase involved in this response.
